GABELLI FUNDS LLC - FURIEX PHARMACEUTICALS INC ownership

FURIEX PHARMACEUTICALS INC's ticker is FURX and the CUSIP is 36106P101. A total of 108 filers reported holding FURIEX PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 7.81 and the average weighting 0.1%.

Quarter-by-quarter ownership
GABELLI FUNDS LLC ownership history of FURIEX PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2014$12,105,000114,0000.06%
Other shareholders
FURIEX PHARMACEUTICALS INC shareholders Q2 2014
NameSharesValueWeighting ↓
JAY JEFFREY R 494,100$16,834,00013.30%
Consonance Capital Management LP 650,608$22,166,0007.88%
Global Alpha Capital Management Ltd. 111,246$3,998,0003.98%
Breithorn Capital Management 60,000$2,044,0001.35%
Artal Group S.A. 914,442$31,155,0000.98%
Montibus Capital Management LLC 146,446$4,989,415,0000.63%
683 Capital Management, LLC 50,000$1,704,0000.57%
FRANKLIN STREET ADVISORS INC /NC 45,450$1,548,0000.38%
Spark Investment Management LLC 33,600$1,141,0000.31%
THOMPSON SIEGEL & WALMSLEY LLC 374,577$12,761,0000.28%
View complete list of FURIEX PHARMACEUTICALS INC shareholders